Performance of age-adjusted and fixed threshold D-dimer to exclude DVT in those with low pre-test probability - Single centre experience.

Autor: Gazes A; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, United Kingdom., Speed V; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, United Kingdom; Bennett Institute for Applied Data Science, Nuffield Department of Primary Care Health Sciences, University of Oxford, United Kingdom. Electronic address: v.speed@nhs.net., Czuprynska JR; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, United Kingdom., Vadher B; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, United Kingdom., Arya R; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, United Kingdom., Roberts LN; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, United Kingdom; Institute of Pharmaceutical Science, King's College London, United Kingdom.

Publikováno v: Thrombosis research [Thromb Res] 2023 Dec; Vol. 232, pp. 1-5. Date of Electronic Publication: 2023 Oct 18.

Rivaroxaban for the treatment of superficial vein thrombosis, experience at King's College Hospital.

Autor: Clapham RE; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK., Speed V; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK.; Institute of Pharmaceutical Sciences, King's College London, London, UK., Czuprynska J; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK., Gazes A; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK., Guppy S; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK., Patel RK; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK., Rea C; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK., Vadher B; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK., Arya R; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK., Roberts LN; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK.

Publikováno v: British journal of haematology [Br J Haematol] 2022 Jan; Vol. 196 (1), pp. e3-e6. Date of Electronic Publication: 2021 Aug 05.

Switching warfarin patients to a direct oral anticoagulant during the Coronavirus Disease-19 pandemic.

Autor: Patel R; Department of Haematological Medicine, Kings College Hospital, United Kingdom of Great Britain and Northern Ireland. Electronic address: rachnapatel1@nhs.net., Czuprynska J; Department of Haematological Medicine, Kings College Hospital, United Kingdom of Great Britain and Northern Ireland., Roberts LN; Department of Haematological Medicine, Kings College Hospital, United Kingdom of Great Britain and Northern Ireland., Vadher B; Department of Haematological Medicine, Kings College Hospital, United Kingdom of Great Britain and Northern Ireland., Rea C; Department of Haematological Medicine, Kings College Hospital, United Kingdom of Great Britain and Northern Ireland., Patel R; Department of Haematological Medicine, Kings College Hospital, United Kingdom of Great Britain and Northern Ireland., Gee E; Department of Haematological Medicine, Kings College Hospital, United Kingdom of Great Britain and Northern Ireland., Saul G; Department of Haematological Medicine, Kings College Hospital, United Kingdom of Great Britain and Northern Ireland., Coles E; Department of Haematological Medicine, Kings College Hospital, United Kingdom of Great Britain and Northern Ireland., Brown A; Department of Haematological Medicine, Kings College Hospital, United Kingdom of Great Britain and Northern Ireland., Byrne R; Department of Haematological Medicine, Kings College Hospital, United Kingdom of Great Britain and Northern Ireland., Speed V; Department of Haematological Medicine, Kings College Hospital, United Kingdom of Great Britain and Northern Ireland., Patel JP; Department of Haematological Medicine, Kings College Hospital, United Kingdom of Great Britain and Northern Ireland., Arya R; Department of Haematological Medicine, Kings College Hospital, United Kingdom of Great Britain and Northern Ireland.

Publikováno v: Thrombosis research [Thromb Res] 2021 Jan; Vol. 197, pp. 192-194. Date of Electronic Publication: 2020 Nov 07.

Fixed dose rivaroxaban can be used in extremes of bodyweight: A population pharmacokinetic analysis.

Autor: Speed V; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK.; Institute of Pharmaceutical Science, King's College London, London, UK., Green B; Model Answers R&D, Brisbane, QLD, Australia., Roberts LN; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK., Woolcombe S; Department of Oral Surgery, King's College Hospital NHS Foundation Trust, London, UK., Bartoli-Abdou J; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK., Barsam S; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK., Byrne R; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK., Gee E; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK., Czuprynska J; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK., Brown A; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK., Duffy S; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK., Vadher B; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK., Patel R; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK., Scott V; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK., Gazes A; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK., Patel RK; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK., Arya R; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK., Patel JP; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK.; Institute of Pharmaceutical Science, King's College London, London, UK.

Publikováno v: Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2020 Sep; Vol. 18 (9), pp. 2296-2307.

Prothrombin times in the presence of edoxaban - in-vivo experience from King's College hospital.

Autor: Patel JP; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital Foundation NHS Trust, London, UK.; Institute of Pharmaceutical Science, King's College London, London, UK., Chitongo PB; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital Foundation NHS Trust, London, UK., Dighe P; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital Foundation NHS Trust, London, UK., Roberts LN; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital Foundation NHS Trust, London, UK., Vadher B; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital Foundation NHS Trust, London, UK., Patel RK; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital Foundation NHS Trust, London, UK., Arya R; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital Foundation NHS Trust, London, UK.

Publikováno v: British journal of haematology [Br J Haematol] 2019 Feb; Vol. 184 (3), pp. 455-456. Date of Electronic Publication: 2018 Jan 07.